Hematology/Oncology

Top Story

VIDEO: Novel agent improves response rate in urothelial cancer

June 27, 2017

CHICAGO – A novel antibody drug conjugate demonstrated promising activity among patients with metastatic urothelial cancer, according to a study presented at the ASCO Annual Meeting.

‘Lives of our patients are at stake’ as concerns about Senate health care bill mount

June 27, 2017
The cost savings that would be realized under the Senate’s proposed health care bill would have a dramatic negative effect on the quality of health care offered in…
In the Journals

Mortality risk likely to be higher among uninsured patients

June 27, 2017
With the Congressional Budget Office report indicating that 22 million Americans will lose insurance coverage by 2026 under
In the Journals Plus

Hypofractionated radiotherapy may improve glottic cancer survival

June 27, 2017
Hypofractionated radiotherapy improved survival in patients with early-stage glottic cancer compared with conventionally fractionated radiotherapy, according to a study…
FDA News

FDA releases plan to expedite, promote generic drug development

June 27, 2017
As part of its effort to increase competition in the prescription drug market, the FDA released a list of drugs that are off-patent and off-exclusivity without approved…
More News Headlines »
CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant…
More »
Video
Meeting News

VIDEO: Pembrolizumab may improve response to CAR T-cell therapy in children with ALL

June 20, 2017
More »
Featured

CME

Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement